Slideshow Preferred Stock Offerings

By Preferred Stock Channel Staff, updated Sun, June 14, 10:04 PM

Slide #189. Trillium Therapeutics Inc. Preferred Stock Offering

Company: Trillium Therapeutics Inc. (NASDAQ:TRIL)
Date announced: 1/22/2020
Shares Offered: 35,731,818
Date of Pricing: 1/23/2020
Price Per Share: $2.75
Preferred Stock Offering Details: Trillium Therapeutics Inc. ("Trillium" or the "Company") (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has commenced a public offering of common shares (the "Common Shares") of the Company and Series II Non-Voting Convertible First Preferred Shares (the "Series II First Preferred Shares") of the Company (the "Offering"). In addition, Trillium intends to grant the underwriters a 30-day option to purchase up to an additional amount of Common Shares equal to 15% of the Common Shares and Series II First Preferred Shares offered in the Offering. -updated 1/23- Trillium Therapeutics Inc. ("Trillium" or the "Company") (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has priced its previously announced underwritten public offering of 35,731,818 common shares (the "Common Shares") of the Company and 1,250,000 Series II Non-Voting Convertible First Preferred Shares (the "Series II First Preferred Shares") of the Company (the "Offering"). The Common Shares are being sold at a public offering price of US$2.75 per Common Share and the Series II First Preferred Shares are being sold at a public offering price of US$2.75 per Series II First Preferred Share. In connection with the Offering, Trillium has granted the underwriters a 30-day option to purchase up to an additional 5,547,272 Common Shares.

Learn more about the TRIL Defiance Trillion Dollar Club Index ETF at ETF Channel.
Open the TRIL Page at Preferred Stock Channel »

Name: 
Defiance Trillion Dollar Club Index ETF
Website: 
www.trilliumtherapeutics.com
Sector: 
Drugs & Pharmaceuticals
 

Open the TRIL Page at Preferred Stock Channel (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree TRIL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Hold (2.33 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com

Browse preferred stock yield screens, safer-income pages, offerings research, valuation and liquidation-preference screens, and related market idea pages from across the channel network. These links are grouped by topic to make the list easier to scan.

Preferred Yield and Income Screens

Core PreferredStockChannel pages focused on high-yield preferreds, socially responsible income ideas, and safer-income preferred research.

Offerings, Structure, and Screening Tools

Pages for recent preferred offerings, preferreds by index membership or industry, and insider-related screening ideas.

Premium, Discount, and Relative Value Screens

Pages centered on preferred stock pricing relative to liquidation preference and comparative value signals.

Dividend and Cross-Network Income Research

Related dividend and income pages from across the network that support preferred-stock investors comparing income vehicles.

Analyst and Broader Market Research

Broader analyst and market pages that remain part of the live homepage inventory.